首页 > 最新文献

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery最新文献

英文 中文
The 10 Commandments for Distal Management of Type A Dissection. A型解剖远端处理的十诫。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-11-26 DOI: 10.1177/15569845251394392
Kim I de la Cruz
{"title":"The 10 Commandments for Distal Management of Type A Dissection.","authors":"Kim I de la Cruz","doi":"10.1177/15569845251394392","DOIUrl":"10.1177/15569845251394392","url":null,"abstract":"","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"523-531"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145632844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Outcomes of Right Anterior Minithoracotomy and Ministernotomy for Aortic Valve Replacement: An Updated Meta-Analysis. 主动脉瓣置换术中右前小胸切开术和小胸切开术的比较结果:一项最新的荟萃分析。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-12-02 DOI: 10.1177/15569845251396471
Kristine Santos, Clara Campoverde Fárez, Victoria Zecchin Ferrara, Kensei Oya, Miguel Angel Samaniego, Melissa Chacón Quirós, Victor Lopez Barrios, Tomasz Plonek

Objective: Right anterior minithoracotomy (RAMT) and ministernotomy (MS) are established approaches for minimally invasive aortic valve replacement (MIAVR). There is no consensus about which technique offers better results.

Methods: A literature search was conducted in MEDLINE, Scopus, and Cochrane Library, focusing on studies that compared RAMT and MS for MIAVR. RevMan 8.13.0 (The Cochrane Collaboration, London, UK) was used to calculate effect estimates reported as odds ratios (ORs) or mean differences (MDs) with 95% confidence intervals (CIs).

Results: We included 21 studies with 6,986 patients, of whom 45.8% underwent RAMT. RAMT was associated with a shorter hospital stay (MD = -0.8 days, 95% CI: -1.4 to -0.2, P = 0.002) and reduced blood loss (MD = -22.3 mL, 95% CI: -32.8 to -11.8, P < 0.001), transfusion rates (OR = 0.7, 95% CI: 0.5 to 0.9, P = 0.01), and incidence of acute kidney injury (AKI; OR = 0.7, 95% CI: 0.5 to 0.9, P = 0.02). However, RAMT was also associated with a slightly longer cardiopulmonary bypass (CPB) time (MD = 9.0 min, 95% CI: 0.7 to 17.3, P = 0.03, I² = 97%) and incisional pain score (standardized MD = 0.5, 95% CI: 0.4 to 0.6, P < 0.001). Mortality, stroke, and other complications were similar between the 2 techniques.

Conclusions: RAMT offers advantages including shorter hospital stay and reduced blood loss, transfusion, and AKI rates but at the cost of slightly longer CPB time and greater incisional pain. These findings underscore the need for individualized patient selection based on surgical risk, anatomical considerations, and recovery priorities.

目的:右前小胸切开术(RAMT)和小胸切开术(MS)是微创主动脉瓣置换术(MIAVR)的常用入路。对于哪种技术能提供更好的结果,目前还没有达成共识。方法:在MEDLINE、Scopus和Cochrane图书馆进行文献检索,重点比较RAMT和MS对MIAVR的影响。使用RevMan 8.13.0 (The Cochrane Collaboration, London, UK)计算以95%置信区间(ci)的优势比(ORs)或平均差异(MDs)报告的效果估计。结果:我们纳入了21项研究,6986例患者,其中45.8%接受了RAMT。RAMT与缩短住院时间(MD = -0.8天,95% CI: -1.4至-0.2,P = 0.002)、减少失血量(MD = -22.3 mL, 95% CI: -32.8至-11.8,P < 0.001)、输血率(OR = 0.7, 95% CI: 0.5至0.9,P = 0.01)和急性肾损伤发生率(AKI; OR = 0.7, 95% CI: 0.5至0.9,P = 0.02)相关。然而,RAMT也与稍长的体外循环(CPB)时间(MD = 9.0 min, 95% CI: 0.7 ~ 17.3, P = 0.03, I²= 97%)和切口疼痛评分(标准化MD = 0.5, 95% CI: 0.4 ~ 0.6, P < 0.001)相关。两种方法的死亡率、卒中和其他并发症相似。结论:RAMT的优点包括缩短住院时间,减少失血、输血和AKI发生率,但代价是CPB时间略长,切口疼痛更大。这些发现强调了根据手术风险、解剖考虑和恢复优先级对患者进行个性化选择的必要性。
{"title":"Comparative Outcomes of Right Anterior Minithoracotomy and Ministernotomy for Aortic Valve Replacement: An Updated Meta-Analysis.","authors":"Kristine Santos, Clara Campoverde Fárez, Victoria Zecchin Ferrara, Kensei Oya, Miguel Angel Samaniego, Melissa Chacón Quirós, Victor Lopez Barrios, Tomasz Plonek","doi":"10.1177/15569845251396471","DOIUrl":"10.1177/15569845251396471","url":null,"abstract":"<p><strong>Objective: </strong>Right anterior minithoracotomy (RAMT) and ministernotomy (MS) are established approaches for minimally invasive aortic valve replacement (MIAVR). There is no consensus about which technique offers better results.</p><p><strong>Methods: </strong>A literature search was conducted in MEDLINE, Scopus, and Cochrane Library, focusing on studies that compared RAMT and MS for MIAVR. RevMan 8.13.0 (The Cochrane Collaboration, London, UK) was used to calculate effect estimates reported as odds ratios (ORs) or mean differences (MDs) with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>We included 21 studies with 6,986 patients, of whom 45.8% underwent RAMT. RAMT was associated with a shorter hospital stay (MD = -0.8 days, 95% CI: -1.4 to -0.2, <i>P</i> = 0.002) and reduced blood loss (MD = -22.3 mL, 95% CI: -32.8 to -11.8, <i>P</i> < 0.001), transfusion rates (OR = 0.7, 95% CI: 0.5 to 0.9, <i>P</i> = 0.01), and incidence of acute kidney injury (AKI; OR = 0.7, 95% CI: 0.5 to 0.9, <i>P</i> = 0.02). However, RAMT was also associated with a slightly longer cardiopulmonary bypass (CPB) time (MD = 9.0 min, 95% CI: 0.7 to 17.3, <i>P</i> = 0.03, I² = 97%) and incisional pain score (standardized MD = 0.5, 95% CI: 0.4 to 0.6, <i>P</i> < 0.001). Mortality, stroke, and other complications were similar between the 2 techniques.</p><p><strong>Conclusions: </strong>RAMT offers advantages including shorter hospital stay and reduced blood loss, transfusion, and AKI rates but at the cost of slightly longer CPB time and greater incisional pain. These findings underscore the need for individualized patient selection based on surgical risk, anatomical considerations, and recovery priorities.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"534-546"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Multifocal Benign Acquired Bronchoesophageal Fistulas. 多灶性良性获得性支气管食管瘘的治疗。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-10-03 DOI: 10.1177/15569845251382592
Valeda Yong, Sameer Patel, Gerard Criner, Whitney Burrows, Nathaniel Marchetti, Roh Yanagida, Kewal Krishan, Parag Desai, Charles Bakhos
{"title":"Management of Multifocal Benign Acquired Bronchoesophageal Fistulas.","authors":"Valeda Yong, Sameer Patel, Gerard Criner, Whitney Burrows, Nathaniel Marchetti, Roh Yanagida, Kewal Krishan, Parag Desai, Charles Bakhos","doi":"10.1177/15569845251382592","DOIUrl":"10.1177/15569845251382592","url":null,"abstract":"","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"599-600"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145212663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and Automation of Intracorporeal Organ Digestion. 体内器官消化的可行性及自动化。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-11-25 DOI: 10.1177/15569845251392568
Jerry Liu, Lindsay Nitsche, Michael Demmy, Saraswati Pokharel, Todd L Demmy

Objective: We aimed to study the feasibility and automation of intracorporeal lung specimen dissolution using NaOH to decrease specimen extraction trauma.

Methods: Twenty-three cadaveric porcine lungs were weighed, cannulated, placed in laparoscopic tissue extraction sacs, and submerged in water baths (37 °C). Lungs were digested for 6 to 36 h with dissolution fluid replacement through various cannulation strategies. Dissolution was quantified by changes in solid mass and structural and histologic integrities. After optimization, we performed 24-hour lung dissolution in a cadaveric porcine model. Next, a system was built using polyvinyl chloride, solenoid valves, water flow sensors, tubing, a vacuum pump, and an Arduino UNO (Monza, Italy). Flow tests were performed. System feasibility and safety were tested. A vacuum chamber was added for gentle agitation to the digestion solution through fluid oscillation. Functional tests were repeated.

Results: There were no containment failures. Compared with saline, NaOH exhibited significant dissolution by 6 h (P < 0.001) progressing to a port-extractable, jelly-like material by 24 h (<20% initial mass). The degeneration of parenchymal histology correlated with NaOH exposure (r = 0.98, P = 0.02). Neither enzyme use (P = 0.3) nor specimen vascular cannulation (P = 0.15) improved dissolution compared with bathing. At 24 h, the clinical emulation model demonstrated no leaks and lung tissue effects proportionate to volume of delivered lye. During the flow tests, inflow was more precise, with minimal deviation. Outflow was more accurate, with measurements closer to the true value. The system passed 6-hour safety tests without leaks, with and without the vacuum chamber.

Conclusions: These preliminary results suggest that automation of intracorporeal lung specimen digestion is feasible.

目的:探讨氢氧化钠体外溶出肺标本的可行性和自动化程度,以减少标本提取的创伤。方法:将23只死猪肺称重,插管,置于腹腔镜组织提取囊中,浸泡在37°C的水浴中。肺消化6 ~ 36 h,通过不同的插管策略置换溶解液。溶解通过固体质量、结构和组织学完整性的变化来量化。优化后,我们在猪尸体模型中进行了24小时肺溶出。接下来,使用聚氯乙烯、电磁阀、水流传感器、管道、真空泵和Arduino UNO(意大利蒙扎)构建了一个系统。进行了流量测试。测试了系统的可行性和安全性。加入真空室,通过流体振荡对溶出液进行温和搅拌。重复进行功能测试。结果:无包膜失效。与生理盐水相比,NaOH在6小时内表现出显著的溶解(P < 0.001),并在24小时内形成可提取的果冻状物质(r = 0.98, P = 0.02)。与浸泡相比,使用酶(P = 0.3)和标本血管插管(P = 0.15)都没有改善溶出度。24小时时,临床模拟模型显示无泄漏,肺组织效应与输送的碱液体积成正比。在流动测试中,流入更加精确,偏差最小。流出量更准确,测量值更接近真实值。该系统通过了6小时的安全测试,没有泄漏,有真空室和没有真空室。结论:这些初步结果提示体外肺标本消化自动化是可行的。
{"title":"Feasibility and Automation of Intracorporeal Organ Digestion.","authors":"Jerry Liu, Lindsay Nitsche, Michael Demmy, Saraswati Pokharel, Todd L Demmy","doi":"10.1177/15569845251392568","DOIUrl":"10.1177/15569845251392568","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to study the feasibility and automation of intracorporeal lung specimen dissolution using NaOH to decrease specimen extraction trauma.</p><p><strong>Methods: </strong>Twenty-three cadaveric porcine lungs were weighed, cannulated, placed in laparoscopic tissue extraction sacs, and submerged in water baths (37 °C). Lungs were digested for 6 to 36 h with dissolution fluid replacement through various cannulation strategies. Dissolution was quantified by changes in solid mass and structural and histologic integrities. After optimization, we performed 24-hour lung dissolution in a cadaveric porcine model. Next, a system was built using polyvinyl chloride, solenoid valves, water flow sensors, tubing, a vacuum pump, and an Arduino UNO (Monza, Italy). Flow tests were performed. System feasibility and safety were tested. A vacuum chamber was added for gentle agitation to the digestion solution through fluid oscillation. Functional tests were repeated.</p><p><strong>Results: </strong>There were no containment failures. Compared with saline, NaOH exhibited significant dissolution by 6 h (<i>P</i> < 0.001) progressing to a port-extractable, jelly-like material by 24 h (<20% initial mass). The degeneration of parenchymal histology correlated with NaOH exposure (<i>r</i> = 0.98, <i>P</i> = 0.02). Neither enzyme use (<i>P</i> = 0.3) nor specimen vascular cannulation (<i>P</i> = 0.15) improved dissolution compared with bathing. At 24 h, the clinical emulation model demonstrated no leaks and lung tissue effects proportionate to volume of delivered lye. During the flow tests, inflow was more precise, with minimal deviation. Outflow was more accurate, with measurements closer to the true value. The system passed 6-hour safety tests without leaks, with and without the vacuum chamber.</p><p><strong>Conclusions: </strong>These preliminary results suggest that automation of intracorporeal lung specimen digestion is feasible.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"575-584"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145603954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the Gap: Cost-Effective Modifications in Endoscopic Cardiac Surgery for Resource-Limited Settings. 弥合差距:资源有限的内窥镜心脏手术的成本效益改进。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-11-25 DOI: 10.1177/15569845251394394
Sandip Sardar, Monalisa Datta
{"title":"Bridging the Gap: Cost-Effective Modifications in Endoscopic Cardiac Surgery for Resource-Limited Settings.","authors":"Sandip Sardar, Monalisa Datta","doi":"10.1177/15569845251394394","DOIUrl":"10.1177/15569845251394394","url":null,"abstract":"","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"603-604"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145603890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 10 Commandments for Moving From Direct Vision to Endoscopic Mitral and Tricuspid Surgery Safely. 从直视手术到内窥镜下二尖瓣和三尖瓣安全手术的十诫。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-10-30 DOI: 10.1177/15569845251386448
Tomas Holubec, Philipp Kaiser, Hiwad Rashid, Razan Salem, Florian Hecker, Thomas Walther
{"title":"The 10 Commandments for Moving From Direct Vision to Endoscopic Mitral and Tricuspid Surgery Safely.","authors":"Tomas Holubec, Philipp Kaiser, Hiwad Rashid, Razan Salem, Florian Hecker, Thomas Walther","doi":"10.1177/15569845251386448","DOIUrl":"10.1177/15569845251386448","url":null,"abstract":"","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"517-522"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145400675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Y-Graft Versus In Situ Bilateral Internal Mammary Arteries in Endoscopic Coronary Artery Bypass Grafting. y型移植物与原位双侧乳腺内动脉在内镜下冠状动脉搭桥术中的对比。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-10-03 DOI: 10.1177/15569845251377059
Theresia Feline Husen, Silke van Genechten, Jade Claessens, Loren Packlé, Samuel Heuts, Jos G Maessen, Alaaddin Yilmaz

Objective: The clinical outcomes of bilateral internal mammary arteries (BIMA) in situ were compared with Y-grafts in endoscopic coronary artery bypass grafting (endo-CABG), a less-invasive alternative to conventional CABG, providing reduced trauma and faster recovery.

Methods: A retrospective single-center study was performed from January 2016 until February 2023 on endo-CABG patients, dividing them into in situ BIMA graft or Y-graft recipients. As endo-CABG was performed in all patients requiring surgical revascularization, this represents an unselected cohort. The primary outcome comprised freedom from major adverse cardiac and cerebrovascular events (MACCE). The secondary outcomes were target lesion revascularization (TLR) and 1-year overall survival.

Results: A total of 1,328 endo-CABG patients (BIMA in situ, n = 693; Y-graft, n = 634) were included. Overall, characteristics of both groups were comparable, except that Y-graft patients had more comorbidities (diabetes mellitus and myocardial infarction), which was reflected in the EuroSCORE II. Furthermore, most Y-graft patients had triple-vessel disease and a higher number of bypasses required. The 1-year MACCE-free survival did not differ significantly between the groups (91.9% vs 89%; univariable hazard ratio [HR] = 1.42, 95% CI: 0.96 to 2.11, P = 0.079; multivariable HR = 1.07, 95% CI: 0.70 to 1.63, P = 0.771), as did the 1-year survival rate (95.7% vs 93.2%; univariable HR = 1.67, 95% CI: 1.01 to 2.75, P = 0.046; multivariable HR =1.34, 95% CI: 0.77 to 2.33, P = 0.297). TLR did not differ significantly between groups (univariable HR = 0.68, 95% CI: 0.22 to 2.08, P = 0.499) or after adjustment (multivariable HR = 0.31, 95% CI: 0.08 to 1.24, P = 0.100).

Conclusions: Creating a Y-graft for distal lesions and in cases in which more than 2 anastomoses are required serves as a favorable alternative without a difference between in situ and Y-grafts in 1-year MACCE-free survival.

目的:比较双侧原位乳内动脉(BIMA)与y型移植物在内镜下冠状动脉旁路移植术(内镜下冠状动脉旁路移植术)中的临床效果,内镜下冠状动脉旁路移植术是一种微创的替代方法,创伤小,恢复快。方法:2016年1月至2023年2月,对内镜下cabg患者进行回顾性单中心研究,将其分为原位BIMA受体和y -受体。由于所有需要手术血运重建术的患者都进行了腔内冠脉搭桥,因此这是一个未选择的队列。主要终点包括无主要心脑血管不良事件(MACCE)。次要结果是靶病变血运重建术(TLR)和1年总生存期。结果:共纳入1328例endo-CABG患者(原位BIMA, 693例;Y-graft, 634例)。总的来说,两组的特征是相似的,除了y -移植物患者有更多的合并症(糖尿病和心肌梗死),这在EuroSCORE II中有所反映。此外,大多数y型移植物患者患有三支血管疾病,需要更多的旁路手术。组间1年无macce生存率无显著差异(91.9% vs 89%;单变量风险比[HR] = 1.42, 95% CI: 0.96 ~ 2.11, P = 0.079;多变量风险比[HR] = 1.07, 95% CI: 0.70 ~ 1.63, P = 0.771), 1年生存率也无显著差异(95.7% vs 93.2%;单变量风险比= 1.67,95% CI: 1.01 ~ 2.75, P = 0.046;多变量风险比=1.34,95% CI: 0.77 ~ 2.33, P = 0.297)。各组间TLR差异无统计学意义(单变量HR = 0.68, 95% CI: 0.22 ~ 2.08, P = 0.499)或调整后(多变量HR = 0.31, 95% CI: 0.08 ~ 1.24, P = 0.100)。结论:对于远端病变和需要2个以上吻合口的病例,创建y型移植物是一种有利的选择,在1年无macce生存期中,原位移植和y型移植物没有区别。
{"title":"Y-Graft Versus In Situ Bilateral Internal Mammary Arteries in Endoscopic Coronary Artery Bypass Grafting.","authors":"Theresia Feline Husen, Silke van Genechten, Jade Claessens, Loren Packlé, Samuel Heuts, Jos G Maessen, Alaaddin Yilmaz","doi":"10.1177/15569845251377059","DOIUrl":"10.1177/15569845251377059","url":null,"abstract":"<p><strong>Objective: </strong>The clinical outcomes of bilateral internal mammary arteries (BIMA) in situ were compared with Y-grafts in endoscopic coronary artery bypass grafting (endo-CABG), a less-invasive alternative to conventional CABG, providing reduced trauma and faster recovery.</p><p><strong>Methods: </strong>A retrospective single-center study was performed from January 2016 until February 2023 on endo-CABG patients, dividing them into in situ BIMA graft or Y-graft recipients. As endo-CABG was performed in all patients requiring surgical revascularization, this represents an unselected cohort. The primary outcome comprised freedom from major adverse cardiac and cerebrovascular events (MACCE). The secondary outcomes were target lesion revascularization (TLR) and 1-year overall survival.</p><p><strong>Results: </strong>A total of 1,328 endo-CABG patients (BIMA in situ, <i>n</i> = 693; Y-graft, <i>n</i> = 634) were included. Overall, characteristics of both groups were comparable, except that Y-graft patients had more comorbidities (diabetes mellitus and myocardial infarction), which was reflected in the EuroSCORE II. Furthermore, most Y-graft patients had triple-vessel disease and a higher number of bypasses required. The 1-year MACCE-free survival did not differ significantly between the groups (91.9% vs 89%; univariable hazard ratio [HR] = 1.42, 95% CI: 0.96 to 2.11, <i>P</i> = 0.079; multivariable HR = 1.07, 95% CI: 0.70 to 1.63, <i>P</i> = 0.771), as did the 1-year survival rate (95.7% vs 93.2%; univariable HR = 1.67, 95% CI: 1.01 to 2.75, <i>P</i> = 0.046; multivariable HR =1.34, 95% CI: 0.77 to 2.33, <i>P</i> = 0.297). TLR did not differ significantly between groups (univariable HR = 0.68, 95% CI: 0.22 to 2.08, <i>P</i> = 0.499) or after adjustment (multivariable HR = 0.31, 95% CI: 0.08 to 1.24, <i>P</i> = 0.100).</p><p><strong>Conclusions: </strong>Creating a Y-graft for distal lesions and in cases in which more than 2 anastomoses are required serves as a favorable alternative without a difference between in situ and Y-grafts in 1-year MACCE-free survival.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"547-554"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145212581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Mitral Valve Repair With Adjustable Chords. 可调弦微创二尖瓣修复。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-10-03 DOI: 10.1177/15569845251382595
Oleksandr Babliak, Dmytro Babliak, Serhii Yatsuk
{"title":"Minimally Invasive Mitral Valve Repair With Adjustable Chords.","authors":"Oleksandr Babliak, Dmytro Babliak, Serhii Yatsuk","doi":"10.1177/15569845251382595","DOIUrl":"10.1177/15569845251382595","url":null,"abstract":"","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"593"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145212653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Totally Endoscopic Aortic Valve Replacement With Aortic Annulus and Root Enlargement. 全内窥镜主动脉瓣置换术伴主动脉环和主动脉根扩大。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-11-25 DOI: 10.1177/15569845251392478
Timotheos G Kelpis, Antonios A Pitsis
{"title":"Totally Endoscopic Aortic Valve Replacement With Aortic Annulus and Root Enlargement.","authors":"Timotheos G Kelpis, Antonios A Pitsis","doi":"10.1177/15569845251392478","DOIUrl":"10.1177/15569845251392478","url":null,"abstract":"","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"597-598"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145603898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Endoscopic Systematic Approach to Different Size P2 Prolapses Using a Modified Loop Technique. 内镜系统方法对不同大小的P2脱垂使用改进的环技术。
IF 1.6 Q2 SURGERY Pub Date : 2025-11-01 Epub Date: 2025-11-25 DOI: 10.1177/15569845251391801
Mario Castillo-Sang, Matias Rios, Thomas Wilkinson, Niem Khan, Prashant Nayak, Masroor Alam

Objective: A P2 prolapse comes in all sizes, and the original description of mitral loop repair (premeasured neochords) does not account for prolapse size. This technique "blind spot" can result in residual billowing or prolapse, especially in larger leaflets. Ventricular remodeling after repair can cause neochordal pseudo-elongation that worsens this residual prolapse, leading to regurgitation. We sought to study the effect of P2 prolapse size on neochordal anchoring location on the prolapse. To account for the P2 prolapse size in loop technique, we measured this intraoperatively (edge-to-annulus distance) and anchored the neochords incrementally farther from the leaflet edge in larger prolapses. Neochordal length was measured from the flattened prolapsed leaflet edge to the papillary muscle anchoring point.

Methods: Of 180 endoscopic repairs for degenerative mitral disease, 95 involved P2 neochords and 50 were premeasured (loop technique). We studied the relationship between P2 prolapse size and leaflet neochordal anchoring in 50 P2 prolapses through surgical footage review. Echocardiography at discharge and 3 months provided immediate and short-term follow-up.

Results: All 50 repairs were successful without residual billowing or regurgitation above mild when anchoring neochords based on prolapse size. The P2 prolapses were grouped by size into 4 grades: grade 1 (<1.5 cm, n = 15), grade 2 (1.5 to 2 cm, n = 18), grade 3 (2 to 3 cm, n = 10), and grade 4 (>3 cm, n = 7). Each prolapse grade had consistent neochordal leaflet anchoring away from the edge: grade 1 = 3 mm, grade 2 = 5 to 8 mm, grade 3 = 1 to 1.5 cm, and grade 4 = 1.5 to 2 cm.

Conclusions: Our adaptation of the loop technique to include P2 prolapse size prevents residual billowing or prolapse and prevents suboptimal leaflet anchoring.

目的:P2脱垂有各种大小,二尖瓣环修复的原始描述(预先测量的新索)没有考虑脱垂的大小。这种技术的“盲点”可导致残余的翻腾或脱垂,特别是在较大的小叶中。修复后的心室重构可引起新脊索假性伸长,使残余脱垂恶化,导致反流。我们试图研究P2脱垂大小对脱垂新索锚定位置的影响。为了解释环技术中P2脱垂的大小,我们术中测量了这个(边缘到环的距离),并在较大的脱垂中逐渐将新索固定在离小叶边缘更远的地方。测量从扁平脱垂小叶边缘到乳头肌锚定点的新索索长度。方法:180例退行性二尖瓣病变的内镜修复术中,95例涉及P2新索,50例预先测量(环技术)。我们通过对50例P2脱垂的手术影像回顾,研究了P2脱垂大小与小叶新脊索锚定的关系。出院时和3个月时的超声心动图提供了即时和短期随访。结果:所有50例修复均成功,根据脱垂大小锚定新索时无残余翻腾或轻度以上反流。将P2脱垂按大小分为4个等级:1级(n = 15)、2级(1.5 ~ 2 cm, n = 18)、3级(2 ~ 3 cm, n = 10)、4级(> ~ 3 cm, n = 7)。每个脱垂级别都有一致的新脊索小叶锚定远离边缘:1级= 3mm, 2级= 5 ~ 8mm, 3级= 1 ~ 1.5 cm, 4级= 1.5 ~ 2cm。结论:我们对环技术的调整包括P2脱垂大小,防止残余的翻腾或脱垂,并防止次优的小叶锚定。
{"title":"An Endoscopic Systematic Approach to Different Size P2 Prolapses Using a Modified Loop Technique.","authors":"Mario Castillo-Sang, Matias Rios, Thomas Wilkinson, Niem Khan, Prashant Nayak, Masroor Alam","doi":"10.1177/15569845251391801","DOIUrl":"10.1177/15569845251391801","url":null,"abstract":"<p><strong>Objective: </strong>A P2 prolapse comes in all sizes, and the original description of mitral loop repair (premeasured neochords) does not account for prolapse size. This technique \"blind spot\" can result in residual billowing or prolapse, especially in larger leaflets. Ventricular remodeling after repair can cause neochordal pseudo-elongation that worsens this residual prolapse, leading to regurgitation. We sought to study the effect of P2 prolapse size on neochordal anchoring location on the prolapse. To account for the P2 prolapse size in loop technique, we measured this intraoperatively (edge-to-annulus distance) and anchored the neochords incrementally farther from the leaflet edge in larger prolapses. Neochordal length was measured from the flattened prolapsed leaflet edge to the papillary muscle anchoring point.</p><p><strong>Methods: </strong>Of 180 endoscopic repairs for degenerative mitral disease, 95 involved P2 neochords and 50 were premeasured (loop technique). We studied the relationship between P2 prolapse size and leaflet neochordal anchoring in 50 P2 prolapses through surgical footage review. Echocardiography at discharge and 3 months provided immediate and short-term follow-up.</p><p><strong>Results: </strong>All 50 repairs were successful without residual billowing or regurgitation above mild when anchoring neochords based on prolapse size. The P2 prolapses were grouped by size into 4 grades: grade 1 (<1.5 cm, <i>n</i> = 15), grade 2 (1.5 to 2 cm, <i>n</i> = 18), grade 3 (2 to 3 cm, <i>n</i> = 10), and grade 4 (>3 cm, <i>n</i> = 7). Each prolapse grade had consistent neochordal leaflet anchoring away from the edge: grade 1 = 3 mm, grade 2 = 5 to 8 mm, grade 3 = 1 to 1.5 cm, and grade 4 = 1.5 to 2 cm.</p><p><strong>Conclusions: </strong>Our adaptation of the loop technique to include P2 prolapse size prevents residual billowing or prolapse and prevents suboptimal leaflet anchoring.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"560-566"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145603866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1